treatment
Bone Marrow and Stem Cell Transplantation
Amer Zeidan, MBBS
Zeidan, Amer
Assistant Professor Of Medicine (hematology)
Yale University and Yale Cancer Center
Online Profile:
Privacy and Other Policies
AAMDSIF is committed to operating with the highest level of accountability and transparency. Please click through to each category of policy for more information.
The Nurse’s Role in Preparing Patients for Stem Cell Transplantation
Timothy Graubert, MD
Graubert, Timothy
Director, Hematologic Malignancies Program, Hagler Family Chair in Oncology, Professor of Medicine
Massachusetts General Hospital, Harvard Medical School
Dr. Graubert’s research focuses on the molecular pathogenesis of myeloid leukemias. While at Washington University in St. Louis, he and his colleagues used genome sequencing technology extensively to gain insights into the genetic basis of human cancer and to use this information to improve risk stratification tools and identify targets for novel therapy. Their group published the first complete genome sequence of a human cancer (
Mikkael Sekeres, MD, MS
Nimer, Stephen
Physician Liaison in Hematology and Chief of the Division of Hematology in the Department of Medicine
Sylvester Comprehensive Cancer Center and University of Miami
Mikkael A. Sekeres, MD, MS has been Medical Advisory Board Co-Chair since 2004. He is currently the Physician Liaison in Hematology and Chief of the Division of Hematology at the Sylvester Comprehensive Center at the University. Previously, Dr. Sekeres was the professor of medicine, director of the leukemia program, and Vice Chair for
Patient Advisory Council
The AAMDSIF Patient Advisory Council (PAC) was created in 2008. Its purpose is to serve as a resource to the AAMDSIF staff in the development and review of patient education materials, programs and services. Members of the PAC include doctors, nurses, patient educators, patients and caregivers, all of whom have an interest in supporting the needs of people living with aplastic anemia, MDS, PNH or another bone marrow failure disease. Review by the PAC provides patients and their families with the full confidence that they are receiving the most accurate, reliable and up-to-date information from the Foundation.